20

2018

Welsh Carson Anderson & Stowe (WCAS), one of the world’s leading private equity investors, purchased Abzena in 2018. At this time the company was comprised of three locations including Cambridge, UK, Bristol PA, USA and San Diego CA, USA.

2020

Since the acquisition, WCAS has significantly invested in late phase and commercial cGMP manufacturing facilities in San Diego, CA and Bristol, PA.

2022

New investments include a new biologics manufacturing plant capable of large scale and clinical and commercial production in Sanford, NC, USA.